Chairman of The Board CEO of Exact Sciences Picks Up 2.7 percent More Stock
| RYCFX Fund | USD 53.83 0.12 0.22% |
Slightly above 62% of Biotechnology Fund's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Fund Class mutual fund suggests that many investors are alarmed at this time. Biotechnology Fund's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Fund's earnings reports, geopolitical events, and overall market trends.
BIOTECHNOLOGY |
Those following along with Exact Sciences Corporation will no doubt be intrigued by the recent purchase...
Read at simplywall.st
 |
Biotechnology Fund Fundamental Analysis
We analyze Biotechnology Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Biotechnology Fund is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Biotechnology Fund Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Fund mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Fund could also be used in its relative valuation, which is a method of valuing Biotechnology Fund by comparing valuation metrics with similar companies.
Peers
Biotechnology Fund Related Equities
| LGLSX | L Abbett | 0.95 | ||||
| EIPIX | Eip Growth | 0.90 | ||||
| TRBCX | T Rowe | 0.85 | ||||
| NMFAX | Nationwide Growth | 0.64 | ||||
| APDSX | Artisan Small | 0.45 | ||||
| CHASX | Chase Growth | 0.40 | ||||
| KSCYX | Kinetics Small | 1.52 |
Other Information on Investing in BIOTECHNOLOGY Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether BIOTECHNOLOGY Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTECHNOLOGY with respect to the benefits of owning Biotechnology Fund security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |